JPMorgan Funds - Korea Equity Fund X (acc) - USDRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 37.6 | 8.9 | -19.5 | 10.1 | -7.0 | |
+/-Cat | 3.4 | 12.4 | 1.4 | -3.2 | 1.8 | |
+/-B’mrk | -3.3 | 15.2 | -0.3 | -6.6 | 5.4 | |
Category: Korea Equity | ||||||
Category Benchmark: Morningstar Korea TME NR USD |
Key Stats | ||
NAV 21/11/2024 | USD 189.66 | |
Day Change | -0.18% | |
Morningstar Category™ | Korea Equity | |
ISIN | LU0301639828 | |
Fund Size (Mil) 21/11/2024 | USD 1188.99 | |
Share Class Size (Mil) 21/11/2024 | USD 0.92 | |
Max Initial Charge | - | |
Ongoing Charge 18/07/2024 | 0.16% |
Investment Objective: JPMorgan Funds - Korea Equity Fund X (acc) - USD |
To provide long-term capital growth by investing primarily in a concentrated portfolio of Korean companies. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
John Cho 13/06/2011 | ||
Julian Wong 01/04/2024 | ||
Click here to see others | ||
Inception Date 18/06/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
KOSPI TR KRW | Morningstar Korea TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPMorgan Funds - Korea Equity Fund X (acc) - USD | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
Samsung Electronics Co Ltd | Technology | 9.38 |
SK Hynix Inc | Technology | 9.14 |
Samsung BioLogics Co Ltd | Healthcare | 4.46 |
Hana Financial Group Inc | Financial Services | 4.18 |
LG Chem Ltd | Basic Materials | 3.94 |
Increase Decrease New since last portfolio | ||
JPMorgan Funds - Korea Equity Fund X (acc) - USD |